Corteva, Inc. (NYSE:CTVA) Position Trimmed by Wilkins Investment Counsel Inc.

Wilkins Investment Counsel Inc. cut its stake in shares of Corteva, Inc. (NYSE:CTVA) by 0.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 363,220 shares of the company’s stock after selling 2,375 shares during the period. Corteva comprises about 3.0% of Wilkins Investment Counsel Inc.’s investment portfolio, making the stock its 7th biggest position. Wilkins Investment Counsel Inc.’s holdings in Corteva were worth $20,689,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently bought and sold shares of CTVA. Quest Partners LLC purchased a new position in Corteva during the third quarter valued at $587,000. Pathstone Holdings LLC lifted its position in shares of Corteva by 3.0% in the third quarter. Pathstone Holdings LLC now owns 98,919 shares of the company’s stock valued at $5,815,000 after acquiring an additional 2,846 shares in the last quarter. Prospera Financial Services Inc lifted its position in shares of Corteva by 3.5% in the third quarter. Prospera Financial Services Inc now owns 6,687 shares of the company’s stock valued at $393,000 after acquiring an additional 226 shares in the last quarter. Fifth Third Wealth Advisors LLC lifted its position in shares of Corteva by 13.1% in the third quarter. Fifth Third Wealth Advisors LLC now owns 10,101 shares of the company’s stock valued at $594,000 after acquiring an additional 1,172 shares in the last quarter. Finally, Banque Cantonale Vaudoise lifted its position in shares of Corteva by 234.1% in the third quarter. Banque Cantonale Vaudoise now owns 19,952 shares of the company’s stock valued at $1,173,000 after acquiring an additional 13,981 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CTVA. Barclays boosted their price objective on Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 21st. Bank of America boosted their price objective on Corteva from $69.00 to $73.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. The Goldman Sachs Group initiated coverage on Corteva in a report on Thursday, March 13th. They issued a “buy” rating and a $71.00 target price on the stock. Citigroup lifted their target price on Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Finally, Oppenheimer lifted their target price on Corteva from $70.00 to $72.00 and gave the stock an “outperform” rating in a report on Friday, February 7th. One research analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $68.00.

Insider Activity

In other news, insider Brian Titus sold 26,560 shares of the company’s stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the transaction, the insider now owns 11,347 shares of the company’s stock, valued at approximately $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.20% of the company’s stock.

Corteva Trading Up 1.5 %

Shares of NYSE CTVA opened at $62.50 on Thursday. The business’s 50 day moving average is $62.25 and its two-hundred day moving average is $59.79. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.45 and a quick ratio of 0.93. Corteva, Inc. has a 1-year low of $50.01 and a 1-year high of $66.24. The stock has a market capitalization of $42.85 billion, a P/E ratio of 48.45, a PEG ratio of 1.68 and a beta of 0.79.

Corteva (NYSE:CTVA) last released its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, research analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.09%. Corteva’s dividend payout ratio is 52.71%.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.